Jason A. Okazaki - Feb 16, 2023 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role: CEO and President, Director
Signature: /s/ John O. Gunderson, as Attorney-in-Fact
Stock symbol: ASMB
Transactions as of: Feb 16, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/17/2023, 03:05 PM
Previous filing: Aug 3, 2022
Next filing: Mar 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASMB	Common Stock	Award	$0	+12.5K	+13.21%	$0.00	107K	Feb 16, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.

Content

Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.